Skip to main content

Notes From BIO 2015 #2 Recap And Biotechnology Trends-Gene Therapy, AMR

Despite the magnitude of the problem and dwindling therapeutic options there is limited investment interest in this area.There appears to be few economic incentives for drug companies to develop pipeline in this sector.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.